These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3523741)

  • 1. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment.
    Johansson KE; Tibbling L
    Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
    Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
    Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric acid hypersecretion in refractory gastroesophageal reflux disease.
    Collen MJ; Lewis JH; Benjamin SB
    Gastroenterology; 1990 Mar; 98(3):654-61. PubMed ID: 2298369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
    Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
    Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease.
    Johansson KE; Boeryd B; Johansson K; Tibbling L
    Scand J Gastroenterol; 1986 Sep; 21(7):769-78. PubMed ID: 3535004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
    Collen MJ; Johnson DA; Sheridan MJ
    Dig Dis Sci; 1994 Feb; 39(2):410-7. PubMed ID: 8313826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
    Havelund T; Aalykke C; Rasmussen L
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):509-14. PubMed ID: 9187886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis.
    Pouderoux P; Kahrilas PJ
    Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment with ranitidine compared with fundoplication in gastro-oesophageal reflux disease.
    Johansson KE; Tibbling L
    Scand J Gastroenterol; 1986 Sep; 21(7):779-88. PubMed ID: 3535005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
    Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
    Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
    Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time of administration influences gastric inhibitory effects of ranitidine.
    Johnston DA; Wormsley KG
    Scand J Gastroenterol; 1988 Nov; 23(9):1137-40. PubMed ID: 3247592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid secretion, oesophageal acid reflux, and oesophagitis in patients with symptomatic gastro-oesophageal reflux.
    Matikainen M
    Scand J Gastroenterol; 1981; 16(8):1043-8. PubMed ID: 7336131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease.
    Johansson KE; Ask P; Boeryd B; Fransson SG; Tibbling L
    Scand J Gastroenterol; 1986 Sep; 21(7):837-47. PubMed ID: 3775250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux.
    Gustafsson PM; Kjellman NI; Tibbling L
    Eur Respir J; 1992 Feb; 5(2):201-6. PubMed ID: 1559584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis.
    Ruth M; Enbom H; Lundell L; Lönroth H; Sandberg N; Sandmark S
    Scand J Gastroenterol; 1988 Nov; 23(9):1141-6. PubMed ID: 3073525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal gastric acidity pattern in gastro-oesophageal reflux disease with or without oesophagitis.
    Sozzi M; Valentini M; Poletti M; Bertolissi E; Serraino D; Bovero E; De Iaco F
    Ital J Gastroenterol; 1995; 27(8):413-8. PubMed ID: 8775466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.